Immunohistochemistry improves histopathologic diagnosis in primary aldosteronism

Journal of Clinical Pathology

Volumn 66, Issue 4, 2013, Pages 351-354

  Volpe, Cristia ^a,b   Höög, Anders ^a,c   Ogishima, Tadashi ^d   Mukai, Kuniaki ^e   Lu, Ming ^a   Thorén, Marja ^a,c   Hamberger, Bertil ^a,c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b Division of Endocrinology   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d KYUSHU UNIVERSITY   (Japan)

^e KEIO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ALDOSTERONE SYNTHASE; ENZYME ANTIBODY; HYDROCORTISONE;

ADOLESCENT; ADRENAL GLAND; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; HISTOPATHOLOGY; HORMONE SYNTHESIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; NODULAR HYPERPLASIA; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL;

ADRENAL CORTEX NEOPLASMS; ADRENAL GLANDS; ADRENOCORTICAL ADENOMA; ADULT; AGED; AGED, 80 AND OVER; ALDOSTERONE SYNTHASE; BIOLOGICAL MARKERS; FEMALE; HUMANS; HYPERALDOSTERONISM; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; STEROID 11-BETA-HYDROXYLASE;

EID: 84875211971     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jclinpath-2012-201287     Document Type: Article

References (9)

1. Hannemann A, Wallaschofski H. Prevalence of primary aldosteronism in patient's cohorts and in population-based studies-a review of the current literature. Horm Metab Res 2012;44:157-62.
2. Stowasser M, Sharman J, Leano R, et al. Evidence for abnormal left ventricular structure and function in normotensive individuals with familial hyperaldosteronism type I. J Clin Endocrinol Metab 2005;90:5070-6.
3. Milliez P, Girerd X, Plouin PF, et al. Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol 2005;45:1243-8.
4. Kaplan NM. Current diagnosis and treatment of primary aldosteronism. Expert Rev Cardiovasc Ther 2010;8:1527-30.
5. Lack EE. Atlas of tumor pathology, tumors of the adrenal gland and extra-adrenal paraganglia. Washington: The American Registry of Pathology, The Armed Forces Institute of Pathology, Ser. 4 Fasc. 8, 2007:112-14.
6. DeLellis RA, Lloyd RV, Heitz PU, Eng C, eds. World Health Organization classification of tumours. Pathology and genetics of tumours of endocrine organs. Lyon: IARC Press, 2004:143-6.
7. Enberg U, Volpe C, Hoog A, et al. Postoperative differentiation between unilateral adrenal adenoma and bilateral adrenal hyperplasia in primary aldosteronism by mRNA expression of the gene CYP11B2. Eur J Endocrinol 2004;151:73-85.
8. Nishimoto K, Nakagawa K, Li D, et al. Adrenocortical zonation in humans under normal and pathological conditions. J Clin Endocrinol Metab 2010;95:2296-305.
9. Ogishima T, Shibata H, Shimada H, et al. Aldosterone synthase cytochrome P-450 expressed in the adrenals of patients with primary aldosteronism. J Biol Chem 1991;266:10731-4.